NEW YORK (GenomeWeb News)— Smiths Detection has received a $2.2 million grant from the National Institutes of Health to develop a PCR-based test for multiple influenza types in humans, the London-based company said.

The two-year grant from the National Institute of Allergy and Infectious Diseases will support development of a test that will use LATE PCR technology on the company’s Bio-Seeq instrument and may be administered at the point of care or in a conventional lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.